尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Strome Mark e. Officer active across 2 companies, notably HeartBeam, Inc.. Cumulatively, 10 disclosures have been recorded. Split: 5 buys · 1 sell. Total volume traded: €3.3m. History available since 13 July 2023. The latest transaction was filed on 17 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
STROME MARK E is a declarant linked to Zivo Bioscience, Inc. as a 10% Owner and to HeartBeam, Inc. as a Director. He has 10 filings in total, and across the 10 sampled most recent filings between 2023-07-18 and 2026-04-24, the reported aggregate amounts are EUR 2515697 in buys and EUR 761735 in sells, with Acquisition as the modal transaction nature.